These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 8301234)
1. Cholesterol and sphingomyelin syntheses are regulated independently in cultured human intestinal cells, CaCo-2: role of membrane cholesterol and sphingomyelin content. Chen H; Born E; Mathur SN; Field FJ J Lipid Res; 1993 Dec; 34(12):2159-67. PubMed ID: 8301234 [TBL] [Abstract][Full Text] [Related]
2. Plasma membrane sphingomyelin and the regulation of HMG-CoA reductase activity and cholesterol biosynthesis in cell cultures. Gupta AK; Rudney H J Lipid Res; 1991 Jan; 32(1):125-36. PubMed ID: 2010684 [TBL] [Abstract][Full Text] [Related]
4. Effect of lovastatin on acyl-CoA: cholesterol O-acyltransferase (ACAT) activity and the basolateral-membrane secretion of newly synthesized lipids by CaCo-2 cells. Kam NT; Albright E; Mathur S; Field FJ Biochem J; 1990 Dec; 272(2):427-33. PubMed ID: 2268271 [TBL] [Abstract][Full Text] [Related]
5. Regulation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase in human hepatoma cell line Hep G2. Effects of inhibitors of cholesterol synthesis on enzyme activity. Boogaard A; Griffioen M; Cohen LH Biochem J; 1987 Jan; 241(2):345-51. PubMed ID: 3036060 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of hydroxymethylglutaryl coenzyme A reductase activity does not affect the secretion rate of apolipoproteins B and AI by CaCo-2 cells. Pau E; He Y; Lougheed M; Steinbrecher UP Biochem Cell Biol; 1995; 73(1-2):81-90. PubMed ID: 7662319 [TBL] [Abstract][Full Text] [Related]
7. The rate of sphingomyelin synthesis de novo is influenced by the level of cholesterol in cultured human skin fibroblasts. Leppimäki P; Kronqvist R; Slotte JP Biochem J; 1998 Oct; 335 ( Pt 2)(Pt 2):285-91. PubMed ID: 9761725 [TBL] [Abstract][Full Text] [Related]
8. Effect of a novel squalene epoxidase inhibitor, NB-598, on the regulation of cholesterol metabolism in Hep G2 cells. Hidaka Y; Hotta H; Nagata Y; Iwasawa Y; Horie M; Kamei T J Biol Chem; 1991 Jul; 266(20):13171-7. PubMed ID: 1649182 [TBL] [Abstract][Full Text] [Related]
9. Regulation of 3-hydroxy-3-methylglutaryl-CoA reductase mRNA contents in human hepatoma cell line Hep G2 by distinct classes of mevalonate-derived metabolites. Cohen LH; Griffioen M Biochem J; 1988 Oct; 255(1):61-7. PubMed ID: 2848511 [TBL] [Abstract][Full Text] [Related]
10. Regulation of sterol regulatory element-binding proteins by cholesterol flux in CaCo-2 cells. Field FJ; Born E; Murthy S; Mathur SN J Lipid Res; 2001 Oct; 42(10):1687-98. PubMed ID: 11590226 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of squalene synthase but not squalene cyclase prevents mevalonate-mediated suppression of 3-hydroxy-3-methylglutaryl coenzyme A reductase synthesis at a posttranscriptional level. Peffley DM; Gayen AK Arch Biochem Biophys; 1997 Jan; 337(2):251-60. PubMed ID: 9016820 [TBL] [Abstract][Full Text] [Related]
12. Pravastatin inhibited the cholesterol synthesis in human hepatoma cell line Hep G2 less than simvastatin and lovastatin, which is reflected in the upregulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase and squalene synthase. Cohen LH; van Vliet A; Roodenburg L; Jansen LM; Griffioen M Biochem Pharmacol; 1993 Jun; 45(11):2203-8. PubMed ID: 8517861 [TBL] [Abstract][Full Text] [Related]
13. Regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity and cholesterol biosynthesis by oxylanosterols. Panini SR; Sexton RC; Gupta AK; Parish EJ; Chitrakorn S; Rudney H J Lipid Res; 1986 Nov; 27(11):1190-204. PubMed ID: 3559385 [TBL] [Abstract][Full Text] [Related]
14. Control of cholesterol biosynthesis in Schwann cells. Fu Q; Goodrum JF; Hayes C; Hostettler JD; Toews AD; Morell P J Neurochem; 1998 Aug; 71(2):549-55. PubMed ID: 9681444 [TBL] [Abstract][Full Text] [Related]
15. Sphingomyelin content of intestinal cell membranes regulates cholesterol absorption. Evidence for pancreatic and intestinal cell sphingomyelinase activity. Chen H; Born E; Mathur SN; Johlin FC; Field FJ Biochem J; 1992 Sep; 286 ( Pt 3)(Pt 3):771-7. PubMed ID: 1417735 [TBL] [Abstract][Full Text] [Related]
16. Regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase synthesis in Syrian hamster C100 cells by mevinolin, 25-hydroxycholesterol, and mevalonate: the role of posttranscriptional control. Peffley DM Somat Cell Mol Genet; 1992 Jan; 18(1):19-32. PubMed ID: 1546367 [TBL] [Abstract][Full Text] [Related]
17. In vivo regulation of canine intestinal 3-hydroxy-3-methylglutaryl coenzyme A reductase by cholesterol, lipoprotein, and fatty acids. Gebhard RL; Prigge WF J Lipid Res; 1981 Sep; 22(7):1111-8. PubMed ID: 7299291 [TBL] [Abstract][Full Text] [Related]
18. Regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase by oxysterol by-products of cholesterol biosynthesis. Possible mediators of low density lipoprotein action. Panini SR; Sexton RC; Rudney H J Biol Chem; 1984 Jun; 259(12):7767-71. PubMed ID: 6736025 [TBL] [Abstract][Full Text] [Related]
19. Enhancement of sterol synthesis by the monoterpene perillyl alcohol is unaffected by competitive 3-hydroxy-3-methylglutaryl-CoA reductase inhibition. Cerda SR; Wilkinson J; Branch SK; Broitman SA Lipids; 1999 Jun; 34(6):605-15. PubMed ID: 10405975 [TBL] [Abstract][Full Text] [Related]
20. The novel cholesterol-lowering drug SR-12813 inhibits cholesterol synthesis via an increased degradation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase. Berkhout TA; Simon HM; Patel DD; Bentzen C; Niesor E; Jackson B; Suckling KE J Biol Chem; 1996 Jun; 271(24):14376-82. PubMed ID: 8662919 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]